Evidence map›Paper›PMID 32743010›Full record

ArticleERJ open research2020

Amyloidosis of the respiratory system: 16 patients with amyloidosis initially diagnosed

Masami Yamada, Noboru Takayanagi, Hideaki Yamakawa, Takashi Ishiguro, Tomohisa Baba, Yoshihiko Shimizu, Koji Okudela, Tamiko Takemura, Takashi Ogura

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. A rare presentation of pulmonary transthyretin amyloidosis.Respiratory medicine case reports · 2025
    Article
  4. Respiratory amyloidosis: a case series from a Brazilian referral center.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Masami YamadaDept of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Noboru TakayanagiDept of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Hideaki YamakawaDept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Takashi IshiguroDept of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Tomohisa BabaDept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Yoshihiko ShimizuDept of Diagnostic Pathology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Koji OkudelaDept of Pathobiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tamiko TakemuraDept of Pathology, Japanese Red Cross Medical Center, Tokyo, Japan.
Takashi OguraDept of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Saitama Prefecture · JPJapanese Red Cross Medical Center · JPKanagawa Cardiovascular and Respiratory Center · JPSaitama Red Cross Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsMedical records of 16 patients with amyloidosis of the respiratory system were retrospectively analysed. Amyloid was diagnosed by polarisation microscopy using Congo red-stained tissue specimens and classified immunohistochemically.

resultsMedian patient age was 71 years, and median follow-up period was 5 years. Immunoglobulin light-chain (AL)-λ amyloidosis was found in eight and AL-κ in five patients. Two patients harboured wild-type transthyretin and one harboured serum amyloid A-derived amyloid. Five different forms of amyloidosis of the respiratory system were observed: nodular pulmonary amyloidosis (seven patients), diffuse alveolar-septal amyloidosis (five), mediastinal lymph node amyloidosis (three), tracheobronchial amyloidosis (one), and pleural amyloidosis (one). One patient had diffuse alveolar-septal amyloidosis and mediastinal lymph node amyloidosis. Three of five patients with diffuse alveolar-septal amyloidosis were diagnosed by transbronchial lung biopsy as having concurrent diffuse alveolar haemorrhage or pneumocystis pneumonia. Two of three patients with mediastinal lymph node amyloidosis were diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.

conclusionsNot only nodular pulmonary amyloidosis, diffuse alveolar-septal amyloidosis, and tracheobronchial amyloidosis but also mediastinal lymph node amyloidosis and pleural amyloidosis should be considered in the differential diagnosis of amyloidosis of the respiratory system. Useful diagnostic methods include transbronchial lung biopsy for diffuse alveolar-septal amyloidosis and endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal lymph node amyloidosis.

Identifiers

PMID32743010
PMCPMC7383056
OpenAlexW3044393590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.